Revenue

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Process Solutions Revenue	3.75B	3.52B	Log In	Log In	Log In	Upgrade
Life Science Services Revenue	691.80M	721.80M	Log In	Log In	Log In	Upgrade
Science & Lab Solutions Revenue	4.59B	4.67B	Log In	Log In	Log In	Upgrade
Life Science Revenue	9.03B	8.92B	Log In	Log In	Log In	Upgrade
Oncology Revenue	1.98B	2.01B	Log In	Log In	Log In	Upgrade
Neurology & Immunology Revenue	1.67B	1.69B	Log In	Log In	Log In	Upgrade
Fertility Revenue	1.47B	1.53B	Log In	Log In	Log In	Upgrade
Cardiovascular, Metabolism and Endocrinology Revenue	3.03B	2.95B	Log In	Log In	Log In	Upgrade
Other Healthcare Revenue	315.50M	280.50M	Log In	Log In	Log In	Upgrade
Healthcare Revenue	8.56B	8.45B	Log In	Log In	Log In	Upgrade
Display Solutions Revenue	770.20M	748.30M	Log In	Log In	Log In	Upgrade
Surface Solutions Revenue	342.00M	406.50M	Log In	Log In	Log In	Upgrade
Semiconductor Solutions Revenue	2.57B	2.63B	Log In	Log In	Log In	Upgrade
Electronics Revenue	3.69B	3.79B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Europe Revenue	6.39B	6.17B	Log In	Log In	Log In	Upgrade
North America Revenue	5.60B	5.71B	Log In	Log In	Log In	Upgrade
Asia Pacific Revenue	7.05B	7.02B	Log In	Log In	Log In	Upgrade
Latin America Revenue	1.43B	1.48B	Log In	Log In	Log In	Upgrade
Middle East & Africa Revenue	795.30M	781.20M	Log In	Log In	Log In	Upgrade

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Life Science EBITDA	2.61B	2.59B	Log In	Log In	Log In	Upgrade
Healthcare EBITDA	3.13B	2.99B	Log In	Log In	Log In	Upgrade
Electronics EBITDA	856.40M	969.60M	Log In	Log In	Log In	Upgrade
Corporate/Others EBITDA	-434.20M	-481.80M	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.